Closely Related Influenza Viruses Induce Contrasting Respiratory Tract Immunopathology

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Le, Vy L ^a   Courtney, Cynthia L ^a   Steel, John ^a   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

2009 H1N1 INFLUENZA; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM HYPERPLASIA; EXPERIMENTAL MOUSE; FEMALE; GENE SEQUENCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; INFLUENZA VIRUS A H1N1; LUNG EDEMA; LUNG INFILTRATE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS VIRULENCE; WEIGHT REDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CHEMOKINES; DOGS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; RESPIRATORY MUCOSA; RESPIRATORY TRACT DISEASES; SPECIES SPECIFICITY; VIRAL LOAD; VIRUS REPLICATION;

EID: 84884633720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076708     Document Type: Article

References (48)

1. Morens DM, Taubenberger JK, Harvey HA, Memoli MJ, (2010) The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med 38: e10-e20. doi:10.1097/CCM.0b013e3181c9cc3b. PubMed: 20048675.
2. Kilbourne ED, (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9-14. doi:10.3201/eid1201.051254. PubMed: 16494710.
3. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460. doi:10.1073/pnas.0813234106. PubMed: 19218453.
4. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207. doi:10.1038/nm1477. PubMed: 16964257.
5. Korteweg C, Gu J, (2008) Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172: 1155-1170. doi:10.2353/ajpath.2008.070791. PubMed: 18403604.
6. Morens DM, Taubenberger JK, Fauci AS, (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198: 962-970. doi:10.1086/591708. PubMed: 18710327.
7. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLOS ONE 3: e2985. doi:10.1371/journal.pone.0002985. PubMed: 18716658.
8. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689. doi:10.1056/NEJMoa0904252. PubMed: 19564631.
9. Takiyama A, Wang L, Tanino M, Kimura T, Kawagishi N, et al. (2010) Sudden death of a patient with pandemic influenza (A/H1N1pdm) virus infection by acute respiratory distress syndrome. Jpn J Infect Dis 63: 72-74. PubMed: 20093769.
10. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674-679. doi:10.1056/NEJMoa0904023. PubMed: 19564633.
11. Novel Swine-Origin Influenza AVIT, Dawood FS, Jain S, Finelli L, Shaw MW, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
12. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80. doi:10.1126/science.1119392. PubMed: 16210530.
13. Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79: 14933-14944. doi:10.1128/JVI.79.23.14933-14944.2005. PubMed: 16282492.
14. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, et al. (2006) Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80: 6295-6304. doi:10.1128/JVI.02381-05. PubMed: 16775317.
15. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7: 1306-1312. doi:10.1038/nm1201-1306. PubMed: 11726970.
16. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13: 147-149. doi:10.1038/nm1529. PubMed: 17206149.
17. Lycett SJ, Ward MJ, Lewis FI, Poon AF, Kosakovsky Pond SL, et al. (2009) Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J Virol 83: 9901-9910. doi:10.1128/JVI.00608-09. PubMed: 19625397.
18. Luk J, Gross P, Thompson WW, (2001) Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis 33: 1375-1378. doi:10.1086/322662. PubMed: 11565078.
19. Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, et al. (2011) Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 85: 6844-6855. doi:10.1128/JVI.02200-10. PubMed: 21543489.
20. van Riel D, Leijten LM, van der Eerden M, Hoogsteden HC, Boven LA, et al. (2011) Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLOS Pathog 7: e1002099.
21. La Gruta NL, Kedzierska K, Stambas J, Doherty PC, (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85: 85-92. doi:10.1038/sj.icb.7100026. PubMed: 17213831.
22. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201. doi:10.1126/science.1176225. PubMed: 19465683.
23. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436. doi:10.1038/440435a. PubMed: 16554799.
24. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2006) H5N1 Virus Attachment to Lower Respiratory Tract. Science 312: 399. doi:10.1126/science.1125548. PubMed: 16556800.
25. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483. PubMed: 19574348.
26. Le TV, Mironova E, Garcin D, Compans RW, (2011) Induction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus. PLOS ONE 6: e18780. doi:10.1371/journal.pone.0018780. PubMed: 21533151.
27. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27: 493-497.
28. Le TV, Kim TH, Chaplin DD, (2008) Intraclonal competition inhibits the formation of high-affinity antibody-secreting cells. J Immunol 181: 6027-6037. PubMed: 18941192.
29. Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, et al. (2011) The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J Virol 85: 12825-12829. doi:10.1128/JVI.05930-11. PubMed: 21917963.
30. Xu R, Zhu X, McBride R, Nycholat CM, Yu W, et al. (2012) Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol 86: 9221-9232. doi:10.1128/JVI.00697-12. PubMed: 22718832.
31. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581. PubMed: 17006449.
32. Arai K, Liu ZX, Lane T, Dennert G, (2002) IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol 219: 48-56. doi:10.1016/S0008-8749(02)00584-1. PubMed: 12473267.
33. Cao W, Taylor AK, Biber RE, Davis WG, Kim JH, et al. (2012) Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J Immunol 189: 2257-2265. doi:10.4049/jimmunol.1200168. PubMed: 22855715.
34. Hui KP, Lee SM, Cheung CY, Ng IH, Poon LL, et al. (2009) Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol 182: 1088-1098. PubMed: 19124752.
35. Moore CS, Crocker SJ, (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180: 12-16. doi:10.1016/j.ajpath.2011.09.008. PubMed: 22033229.
36. Neville LF, Mathiak G, Bagasra O, (1997) The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8: 207-219. doi:10.1016/S1359-6101(97)00015-4. PubMed: 9462486.
37. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096. doi:10.1016/j.vaccine.2007.03.046. PubMed: 17544181.
38. Sanders CJ, Vogel P, McClaren JL, Bajracharya R, Doherty PC, et al. (2013) Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels. Am J Physiol Lung Cell Mol Physiol 304: L481-L488. doi:10.1152/ajplung.00343.2012. PubMed: 23355384.
39. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, et al. (2008) Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205: 3065-3077. doi:10.1084/jem.20080201. PubMed: 19064696.
40. Sanders CJ, Doherty PC, Thomas PG, (2011) Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res 343: 13-21. doi:10.1007/s00441-010-1043-z. PubMed: 20848130.
41. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238-244. doi:10.1016/j.coi.2010.01.021. PubMed: 20171075.
42. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC, (2010) Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 84: 7569-7580. doi:10.1128/JVI.00291-10. PubMed: 20504924.
43. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, et al. (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146: 980-991. doi:10.1016/j.cell.2011.08.015. PubMed: 21925319.
44. Reading PC, Whitney PG, Pickett DL, Tate MD, Brooks AG, (2010) Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol Cell Biol 88: 641-650. doi:10.1038/icb.2010.11. PubMed: 20142836.
45. Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, et al. (2001) Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A 98: 2746-2751. doi:10.1073/pnas.031575198. PubMed: 11226311.
46. Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, et al. (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176: 1828-1840. doi:10.2353/ajpath.2010.091087. PubMed: 20110407.
47. Peper RL, Van Campen H, (1995) Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 19: 175-183. doi:10.1006/mpat.1995.0056. PubMed: 8559046.
48. Marsolais D, Hahm B, Walsh KB, Edelmann KH, McGavern D, et al. (2009) A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A 106: 1560-1565. doi:10.1073/pnas.0812689106. PubMed: 19164548.